Purchase Order 75N91023P00653
Award Date
8/1/23
Potential Completion Date
7/31/24
Potential Value
$16K
Federal Agency
National Cancer Institute
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
811310 - Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $15,575 purchase order to Illumina, Inc. of San Diego, California for maintenance services. The one-year firm fixed price contract runs from December 5, 2023 through December 4, 2024 to support the agency's research efforts. As the leading federal funder of biomedical research, the NCI utilizes genomic sequencing technologies from Illumina to advance its mission of...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $20,381.70 firm fixed price purchase order to Illumina, Inc. for unspecified products or services. The place of performance will be in Bethesda, Maryland through September 2023. Illumina will deliver the requested items or work to support the National Cancer Institute, part of the NIH focused on cancer research, treatment, and initiatives to reduce the public health burden of cancer....
Illumina, Inc. was awarded a firm fixed price purchase order valued at $21,185.28 by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract is for bridge maintenance services to be performed at the agency's location in Bethesda, Maryland, with no set-aside designation applied. As a manufacturer and provider of sequencing and array-based solutions, Illumina will likely supply routine maintenance and support for genomic sequencing...
The Department of Health and Human Services, National Institutes of Health, National Cancer Institute awarded a $130,847 firm fixed price purchase order to Illumina, Inc. of San Diego, California. The purpose is to procure preventive maintenance services for a government-owned Illumina NovaSeq 6000 Sequencing System located at the National Cancer Institute in Bethesda, Maryland. The Laboratory of Pathology requires these services to maintain optimal instrument operation, generate comparable...
The National Cancer Institute (NCI) within the National Institutes of Health (NIH) awarded a $205,376.00 firm fixed price purchase order to Illumina, Inc. for maintenance services for a government-owned Illumina NextSeq 2000 sequencing system. The base period runs from February 1, 2024 through January 31, 2028, with the potential for three one-year extensions. The contract provides for annual preventative maintenance, remote technical support, and on-site emergency repairs within two business...
This is a firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), which is part of the U.S. Department of Health and Human Services (DHHS), to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $336,139.00, is for preventive maintenance, emergency service, support, and coverage for a government-owned Illumina micro-array scanner with iScan and RoMa serviceable components. This equipment is critical for...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI) awarded a $154,907.00 firm fixed-price contract to Illumina, Inc. to provide maintenance services for the government-owned Illumina NextSeq500 DNA sequencing system. The contract has a base period of 12 months, with four 12-month option periods. Illumina, as the original equipment manufacturer, will provide preventative maintenance, emergency repair services, software updates,...
The National Cancer Institute (NCI) awarded a $116,652 firm fixed-price purchase order to Illumina, Inc. for preventative maintenance services on an Illumina NextSeq 550 sequencer. The contract was awarded without a set-aside and covers an initial base period from 8/21/2020 to 8/20/2021, with a total performance period through 5/7/2025. Illumina is the original equipment manufacturer (OEM) and the only known provider of these specialized maintenance services. The contract supports the NCI's...
This firm fixed price purchase order, awarded by the National Cancer Institute (NCI) at the National Institutes of Health (NIH), provides maintenance services for seven Illumina sequencing instruments and associated equipment. The $589,617.13 contract with Illumina, Inc., a manufacturer of genomic analysis solutions, has a performance period ending on August 31, 2026. The requirement was competed without any set-aside designation. The contract provides preventative maintenance and emergency...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $93,969.03 firm fixed price delivery order contract to Illumina, Inc. for reagents and consumables. The place of performance will be Illumina's facilities located in San Diego, California. The period of performance is from December 20, 2023 through January 19, 2024. This delivery order was awarded under an existing government-wide acquisition contract vehicle or blanket...